Reduction of Escherichia coli O157:H7 excretion in sheep by oral lactoferrin administration

Veterinary Microbiology

Volumn 150, Issue 3-4, 2011, Pages 373-378

  Atef Yekta, M ^a   Cox, E ^a   Goddeeris, B M ^a,b   Vanrompay, D ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Escherichia coli O157:H7; Lactoferrin; Sheep

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM ANTIBODY; BUFFER; ESCHERICHIA COLI SECRETED PROTEIN A; ESCHERICHIA COLI SECRETED PROTEIN B; IMMUNOGLOBULIN G ANTIBODY; INTIMIN; LACTOFERRIN; UNCLASSIFIED DRUG; VETERINARY DRUG; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL SHEDDING; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI O157; EXPERIMENTAL INFECTION; FECES ANALYSIS; LOW DRUG DOSE; MALE; NONHUMAN; SHEEP; TREATMENT DURATION; TYPE III SECRETION SYSTEM;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL SECRETION SYSTEMS; CATTLE; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FECES; HUMANS; IMMUNOGLOBULIN G; INTESTINES; LACTOFERRIN; SHEEP; SHEEP DISEASES; SHEEP, DOMESTIC;

ANIMALIA; BACTERIA (MICROORGANISMS); BOVINAE; ESCHERICHIA COLI; OVIS ARIES;

EID: 79955953898     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2011.02.052     Document Type: Article

References (37)

1. Appel M.J., van Veen H.A., Vietsch H., Salaheddine M., Nuijens J.H., Ziere B., de Loos F. Sub-chronic (13-week) oral toxicity study in rats with recombinant human lactoferrin produced in the milk of transgenic cows. Food Chem. Toxicol. 2006, 44(7):964-973.
2. Ashida K., Sasaki H., Suzuki Y.A., Lonnerdal B. Cellular internalization of lactoferrin in intestinal epithelial cells. Biometals 2004, 17(3):311-315.
3. Atef Yekta M., Verdonck F., Vanden Broeck W., Goddeeris B.M., Cox E., Vanrompay D. Lactoferrin inhibits E. coli O157:H7 growth and attachment to intestinal epithelial cells. Veterinarni Medicina 2010, 55(8):359-368.
4. Besser R.E., Griffin P.M., Slutsker L. Escherichia coli O157:H7 gastroenteritis and the hemolytic uremic syndrome: an emerging infectious disease. Annu. Rev. Med. 1999, 50:355-367.
5. Brines R.D., Brock J.H. The effect of trypsin and chymotrypsin on the in vitro antimicrobial and iron binding properties of lactoferrin in human milk and bovine colostrum, unusual resistance of human apo-lactoferrin to proteolytic digestion. Biochim. Biophys. Acta 1983, 759(3):229-235.
6. Callaway T.R., Carr M.A., Edrington T.S., Anderson R.C., Nisbet D.J. Diet, Escherichia coli O157:H7, and cattle: a review after 10 years. Curr. Issues Mol. Biol. 2009, 11(2):67-79.
7. Callaway T.R., Edrington T.S., Brabban A.D., Anderson R.C., Rossman M.L., Engler M.J., Carr M.A., Genovese K.J., Keen J.E., Looper M.L., Kutter E.M., Nisbet D.J. Bacteriophage isolated from feedlot cattle can reduce Escherichia coli O157:H7 populations in ruminant gastrointestinal tracts. Foodborne Pathog. Dis. 2008, 5(2):183-191.
8. Callaway T.R., Stahl C.H., Edrington T.S., Genovese K.J., Lincoln L.M., Anderson R.C., Lonergan S.M., Poole T.L., Harvey R.B., Nisbet D.J. Colicin concentrations inhibit growth of Escherichia coli O157:H7 in vitro. J. Food Prot. 2004, 67(11):2603-2607.
9. Curran C.S., Demick K.P., Mansfield J.M. Lactoferrin activates macrophages via TLR4-dependent and -independent signaling pathways. Cell. Immunol. 2006, 242(1):23-30.
10. De la Rosa G., Yang D., Tewary P., Varadhachary A., Oppenheim J.J. Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses. J. Immunol. 2008, 180(10):6868-6876.
11. Dean-Nystrom E.A., Bosworth B.T., Moon H.W. Pathogenesis of Escherichia coli O157:H7 in weaned calves. Adv. Exp. Med. Biol. 1999, 473:173-177.
12. Gallois M., Gidenne T., Tasca C., Caubet C., Coudert C., Milon A., Boullier S. Maternal milk contains antimicrobial factors that protect young rabbits from enteropathogenic Escherichia coli infection. Clin. Vaccine Immunol. 2007, 14(5):585-592.
13. Gifford J.L., Hunter H.N., Vogel H.J. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell. Mol. Life Sci. 2005, 62(22):2588-2598.
14. Gonzalez-Chavez S.A., Arevalo-Gallegos S., Rascon-Cruz Q. Lactoferrin: structure, function and applications. Int. J. Antimicrob. Agents 2009, 33(4).
15. Hoffman M.A., Menge C., Casey T.A., Laegreid W., Bosworth B.T., Dean-Nystrom E.A. Bovine immune response to shiga-toxigenic Escherichia coli O157:H7. Clin. Vaccine Immunol. 2007, 13(12):1322-1327.
16. Hung C.M., Wu S.C., Yen C.C., Lin M.F., Lai Y.W., Tung Y.T., Chen H.L., Chen C.M. Porcine lactoferrin as feedstuff additive elevates avian immunity and potentiates vaccination. Biometals 2010, 23(3):579-587.
17. La Ragione R.M., Best A., Woodward M.J., Wales A.D. Escherichia coli O157:H7 colonization in small domestic ruminants. FEMS Microbiol. Rev. 2009, 33(2):394-410.
18. Legrand D., Mazurier J. A critical review of the roles of host lactoferrin in immunity. Biometals 2010, 23(3):365-376.
19. Mead P.S., Griffin P.M. Escherichia coli O157:H7. Lancet 1998, 352(9135):1207-1212.
20. Molbak K., Mead P.S., Griffin P.M. Antimicrobial therapy in patients with Escherichia coli O157:H7 infection. JAMA 2002, 288(8):1014-1016.
21. Mulder A.M., Connellan P.A., Oliver C.J., Morrisa C.A., Stevenson L.M. Bovine lactoferrin supplementation supports immune and antioxidant status in healthy human males. Nutr. Res. 2008, 28(9):583-589.
22. Ochoa T.J., Noguera-Obenza M., Ebel F., Guzman C.A., Gomez H.F., Cleary T.G. Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli. Infect. Immun. 2003, 71(9):5149-5155.
23. Peterson R.E., Klopfenstein T.J., Moxley R.A., Erickson G.E., Hinkley S., Bretschneider G., Berberov E.M., Rogan D., Smith D.R. Effect of a vaccine product containing type III secreted proteins on the probability of Escherichia coli O157:H7 faecal shedding and mucosal colonization in feedlot cattle. J. Food Prot. 2007, 70(11):2568-2577.
24. Potter A.A., Klashinsky S., Li Y.L., Frey E., Townsend H., Rogan D., Erickson G., Hinkley S., Klopfenstein T., Moxley R.A., Smith D.R., Finlay B.B. Decreased shedding of Escherichia coli O157:H7 by cattle following vaccination with type III secreted proteins. Vaccine 2004, 22(3-4):362-369.
25. Rosenberger G. Clinical Examination of Cattle 1979, Paul Parey, Berlin and Hamburg, Germany.
26. Stephens T.P., McAllister T.A., Stanford K. Development of an experimental model to assess the ability of Escherichia coli O157:H7-inoculated faecal pats to mimic a super shedder within a feedlot environment. J. Food Prot. 2008, 71(3):648-652.
27. Stephens T.P., McAllister T.A., Stanford K. Perineal swabs reveal effect of super shedders on the transmission of Escherichia coli O157:H7 in commercial feedlots. J. Anim. Sci. 2009, 87(12):4151-4160.
28. Teraguchi S., Wakabayashi H., Kuwata H., Yamauchi K., Tamura Y. Protection against infections by oral lactoferrin: evaluation in animal models. Biometals 2004, 17(3):231-234.
29. Tian H., Maddox I.S., Ferguson L.R., Shu Q. Influence of bovine lactoferrin on selected probiotic bacteria and intestinal pathogens. Biometals 2010, 23(3):593-596.
30. Travis S.M., Conway B.A.D., Zabner J., Smith J.J., Anderson N.N., Singh P.K., Greenberg E.P., Welsh M.J. Activity of abundant antimicrobials of the human airway. Am. J. Respir. Cell Mol. Biol. 1999, 20(5):872-879.
31. Varadhachary A., Wolf J.S., Petrak K., O'Malley B.W., Spadaro M., Curcio C., Forni G., Pericle F. Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy. Biochim. Biophys. Acta 2004, 111(3):398-403.
32. Vorland L.H. Lactoferrin: a multifunctional glycoprotein. APMIS 1999, 107(11):971-981.
33. Vande Walle K., Atef Yekta M., Verdonck F., Dezutter L., Cox E. Rectal inoculation of sheep with E. coli O157:H7 results in persistent infection in the absence of a protective immune response. Vet. Microbiol. 2010, 10.1016/j.vetmic.2010.06.033.
34. Vande Walle K., De Zutter L., Cox E. Oral infection with a Shiga toxin-negative Escherichia coli O157:H7 strain elicits humoral and cellular responses but does not protect sheep from colonisation with the homologous strain. Vet. Microbiol. 2010, 10.1016/j.vetmic.2010.09.012.
35. Walker A. Breast milk as the gold standard for protective nutrients. J. Pediatr. 2010, 156(2):S3-S7.
36. Wolff C., Nisan I., Hanski E., Frankel G., Rosenshine I. Protein translocation into host epithelial cells by infecting enteropathogenic Escherichia coli. Mol. Microbiol. 1998, 28(1):143-155.
37. Woodward M.J., Best A., Sprigings K.A., Pearson G.R., Skuse A.M., Wales A., Hayes C.M., Roe J.M., Low J.C., La Ragione R.M. Non-toxigenic Escherichia coli O157:H7 strain NCTC12900 causes attaching-effacing lesions and eae-dependent persistence in weaned sheep. Int. J. Med. Microbiol. 2003, 293(4):299-308.